{
  "id": "622632483a8413c653000081",
  "type": "yesno",
  "question": "Is disruption of immune regulation mechanisms associated with adverse pregnancy outcomes, including preeclampsia (PE)?",
  "ideal_answer": "Inflammation and oxidative stress at the maternal-fetal interface characterize the placental dysfunction that underlies the pregnancy disorder preeclampsia.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34576285",
    "http://www.ncbi.nlm.nih.gov/pubmed/9272206",
    "http://www.ncbi.nlm.nih.gov/pubmed/34847253",
    "http://www.ncbi.nlm.nih.gov/pubmed/32161574",
    "http://www.ncbi.nlm.nih.gov/pubmed/19683334",
    "http://www.ncbi.nlm.nih.gov/pubmed/34412079",
    "http://www.ncbi.nlm.nih.gov/pubmed/21498785",
    "http://www.ncbi.nlm.nih.gov/pubmed/34191338",
    "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
    "http://www.ncbi.nlm.nih.gov/pubmed/32573856",
    "http://www.ncbi.nlm.nih.gov/pubmed/27108670",
    "http://www.ncbi.nlm.nih.gov/pubmed/29756666",
    "http://www.ncbi.nlm.nih.gov/pubmed/34509865",
    "http://www.ncbi.nlm.nih.gov/pubmed/30058156",
    "http://www.ncbi.nlm.nih.gov/pubmed/31608721",
    "http://www.ncbi.nlm.nih.gov/pubmed/24520479",
    "http://www.ncbi.nlm.nih.gov/pubmed/34599631"
  ],
  "snippets": [
    {
      "text": " Maternal systemic and placental inflammatory responses participate in the pathogenesis of hypertensive disorders of pregnancy including preeclampsia, a pregnancy-specific syndrome, although the role of inflammation remains unclear. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34412079",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results indicate these proteins are new factors that play important roles in the immunological pathomechanism of preeclampsia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31608721",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inflammation and oxidative stress at the maternal-fetal interface characterize the placental dysfunction that underlies the pregnancy disorder preeclampsia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32573856",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The abnormal expression of Tim-3 on MDSC might be involved in the pathogenesis of PE, and could be a marker to evaluate the immune function in PE.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34509865",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Maternal immune tolerance is important for maintaining pregnancy, and researchers have increasingly focused on the critical roles of cytokines in the pathogenesis of PE in recent years.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34599631",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of well-controlled immune functions leads to infertility, placental inflammation, and numerous pregnancy complications, including preeclampsia (PE).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32161574",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Effect of Endogenic and Exogenic Oxidative Stress Triggers on Adverse Pregnancy Outcomes: Preeclampsia, Fetal Growth Restriction, Gestational Diabetes Mellitus and Preterm Birth.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34576285",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Disruption of complex immune regulation mechanisms is associated with adverse pregnancy outcomes, including preeclampsia (PE).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34847253",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In addition, it has been demonstrated that immune disturbance may be responsible for some adverse pregnancy outcomes such as preeclampsia (PE), recurrent spontaneous abortion (RSA) and intrauterine growth restriction (IUGR).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520479",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "esponse. In previous models of preeclampsia (PE), defective immune function caused by disruption of lymphangiogenesis was shown to be involved in the disease pathophy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29756666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Increased oxidative stress and immune dysfunction are implicated in preeclampsia (PE) and may contribute to the two- to fourfold increase in PE prevalence among women with type 1 ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21498785",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "r, in preeclampsia, the regulation of immune responses is disrupted as a result of aberrant activation of innate immune cells and imbalanced differentiation of T-helper cell subsets creating a cytotoxic environment in uter",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "a disrupted immune system might be a predisposing factor or result of placental oxidative stress or excessive inflammation in preeclampsia. Preeclampsia c",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "clude insufficient control of inflammation, failure of tolerance toward paternal antigens at the fetal-maternal interface, and subsequent over- or insufficient activation of immune mediators. It is als",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PROBLEM: The purpose of this study is to clarify whether the disruption of immune regulation occurs in early pregnancy before the clinical manifestations of pre",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9272206",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "s review, we focus on the role of excessive systemic inflammation as the result of a dysregulated immune system in the development of preeclampsia. These",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PROBLEM: The purpose of this study is to clarify whether the disruption of immune regulation occurs in early pregnancy before the clinical manifestations of pree",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9272206",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, in preeclampsia, the regulation of immune responses is disrupted as a result of aberrant activation of innate immune cells and imbalanced differentiation of T-helper cell subsets creating a cytotoxic environment in utero.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion, a disrupted immune system might be a predisposing factor or result of placental oxidative stress or excessive inflammation in preeclampsia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "esponse. In previous models of preeclampsia (PE), defective immune function caused by disruption of lymphangiogenesis was shown to be involved in the disease pathoph",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29756666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption of this immune balance and/or inadequate placental perfusion is believed to be associated with a lot of pregnancy-related complications, such as recurrent spontaneous abortion, pre-eclampsia, and fetal intrauterine growth restriction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34191338",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, a delicate immune balance is critical for the maintenance of a successful pregnancy, while disruption of this balance can induce complications such as implantation failure, miscarriage, preterm birth/labor, preeclampsia and fetal growth restriction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30058156",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "antigens during pregnancy. Disruption of complex immune regulation mechanisms is associated with adverse pregnancy outcomes, including preeclampsia (P",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34847253",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ccessful pregnancy. It has been demonstrated that innate immune disturbances may be responsible for some adverse pregnancy outcomes such as preeclamps",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27108670",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ever, in preeclampsia, the regulation of immune responses is disrupted as a result of aberrant activation of innate immune cells and imbalanced differ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PROBLEM: The purpose of this study is to clarify whether the disruption of immune regulation occurs in early pregnancy before the clinical manifestations of preeclampsia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9272206",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, immune maladaptation and hemostatic imbalance have been suggested to be responsible for adverse pregnant outcomes, such as preeclampsia (PE), miscarriage, recurrent spontaneous abortion (RSA) and intrauterine growth restriction (IUGR).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19683334",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PROBLEM: The purpose of this study is to clarify whether the disruption of immune regulation occurs in early pregnancy before the clinical manifestations of preeclampsia.METHOD OF STUDY: The serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF-alpha) were determined by using enzyme-linked immunoadsorbent assay (ELISA) in the first trimester of pregnancy in women who had preeclampsia develop after 28 weeks of pregnancy (preeclamptic group) and in women who completed pregnancy uneventfully (control group).RESULTS: Serum concentrations of both IL-2 and TNF-alpha in the first trimester of the preeclamptic group were significantly higher than those of the control group.CONCLUSIONS: That the perturbation of feto-maternal immune regulation may precede the clinical manifestations of preeclampsia, which may be of relevance i",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9272206",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Preeclampsia can thus be considered a hyperinflammatory state associated with defective regulation of the immune system proposed as a key element in the pathological events of the placental subtype of this disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30079067",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "It has been demonstrated that innate immune disturbances may be responsible for some adverse pregnancy outcomes such as preeclampsia (PE); hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome; intrauterine growth restriction (IUGR); and recurrent spontaneous abortion (RSA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27108670",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}